Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQ2GL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,085
Award facts
- Contract value 100% obligated
- $32,084.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,084.50 delivery order to AmerisourceBergen Drug Corp for Stelara (ustekinumab) 45 mg/0.5 mL syringes under a firm fixed-price contract. The delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. This pharmaceutical product will be performed at the vendor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. Stelara is a biologic immunosuppressant commonly used to treat autoimmune conditions including psoriasis, Crohn's disease, and ulcerative colitis, making this delivery order part of DLA's ongoing efforts to maintain adequate pharmaceutical inventory for military and federal healthcare system requirements.
AmerisourceBergen Drug Corp holds a significant $999,999,999 indefinite delivery vehicle with DLA Troop Support Medical (contract SPE2DX) running through December 2026, which serves as the umbrella agreement under which this delivery order was issued. The company functions as a prime pharmaceutical vendor supplying the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic categories. As a major pharmaceutical distributor and critical healthcare solutions provider, AmerisourceBergen's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements and support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FQ2GL?
SPE2DB25FQ2GL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FQ2GL worth?
The government has obligated $32,085 on SPE2DB25FQ2GL.
Is contract SPE2DB25FQ2GL an order under another contract?
Yes. SPE2DB25FQ2GL is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2GL competed?
The extent of competition for SPE2DB25FQ2GL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award